The chronic, progressive nature of lymphedema and its resistance to conventional treatment has prompted investigation into novel therapeutic approaches, including metabolic interventions that may address underlying pathophysiological mechanisms
#prediabetes #remission #obesity #type2diabetes #met Clinical Assistant Professor of Medicine, Division of Endocrinology , Diplomate of American Board of Obesity Medicine Newly published treatment algorithm for the pharmacologic treatment of obesity and its complications, from the European Association for the Study of Obesity (EASO) Semaglutide and tirzepatide are recommended as first line to treat obesity AND to treat underlying obesity-related complications
1,2 Effective post-overdose interventions remain limited: medications for opioid use disorder reduce repeat overdose risk substantially but reach only a small minority of survivors, and no widely used pharmacotherapy addresses the broader range of substances involved in overdose events
Anti-aging treatments with advanced wellness support and cellular health and rejuvenation wield advanced cutting edge technology to promote cellular repair and rejuvenation, reducing visible signs of aging
